Colorectal cancer, commonly referred to as colon cancer, originates in the colon (large intestine) or rectum, typically as adenomatous polyps. It is unknown what causes cancer yet familial adenomatous polposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC) are thought to increase risk of developing colon cancer. Additionally, increasing age, inflammatory intestinal conditions, nationality, low fiber and high fat diet, diabetes, smoking, alcohol, obesity, and a sedentary lifestyle can contribute to its onset. Treatments for colon cancer include surgery, chemotherapy, radiation therapy, and targeted drug therapy. Stage II colon cancer can be separated into stage IIA, IIB, and IIC. In Stage IIA, the cancer has grown through the muscle layer of the colon wall into the serosa (outer layer). Stage IIB occurs when the colon has developed through the serosa but has not spread to nearby organs. A diagnosis of stage IIC is when the cancer has grown onto nearby organs. At this point, the cancer has not spread to distant locations.
Top Research Reagents
We have 4024 products for the study of Stage Ii Colon Cancer that can be applied to Chromatin Immunoprecipitation (ChIP), Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.